Article
The Incidence of Febrile Neutropenia (FN) for Chemotherapy Patients Receiving pegfilgrastim by an On-body Injector (pegfilgrastim OBI) versus other FN Prophylaxis Strategies
Cancer Research / San Antonio Breast Cancer Symposium 2020
(2020)
Abstract
Jeffrey Crawford; Robert Rifkin; David Dale; Alan Brookhart; Prasad Gawade; Tatiana Lawrence; Rejesh Balani; Gary H Lyman
Disciplines
Publication Date
February 15, 2020
Citation Information
Reshma Mahtani. "The Incidence of Febrile Neutropenia (FN) for Chemotherapy Patients Receiving pegfilgrastim by an On-body Injector (pegfilgrastim OBI) versus other FN Prophylaxis Strategies" Cancer Research / San Antonio Breast Cancer Symposium 2020 Vol. 80 Iss. 4 Supplement (2020) Available at: http://works.bepress.com/reshma-mahtani/27/